SLC22A1 and neoplasm: Notably, when we investigated tumor stage according to BCLC criteria (Figure 7B) and pretreatment with TACE (Figure 7C), no relationship of these conditions with the presence of OCT1 at the plasma membrane of HCC cell was observed.